Achieve Life Sciences Inc
Achieve Life Sciences Inc (ACHV) Covered Calls
As of September 23, 2026, ACHV has 4 covered call opportunities in the coming three months. Return ranges from 28.4 to 60.3% until expiration. Annualized return ranges from 75.6 to 133.9%. The nearest expiration is December 18, 2026. Maximum potential profit is $472.
Read more
Running ACHV covered calls helps you generate consistent income from Achieve Life Sciences Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Achieve Life Sciences Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best ACHV covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if ACHV stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling ACHV covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Achieve Life Sciences Inc covered call is worth writing.
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.
Income-focused investors, long-term ACHV holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling ACHV covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Achieve Life Sciences Inc covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile25.00% Subdued
- Market cap (M$)806
- 52 weeks high-9.38%
- 52 weeks low198.85%
- Analyst recommendationStrong Buy
1.00 - Target price$14.27
82.25% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-05
- P/E—
- Future P/E—
- EPS (ttm)-1.55
- EPS growth next 5 years—
As of September 23, 2026
| 2026-12-18 | 86 | 10.00 | 27.71 | 0.30 | 0.90 | 247.00 | 31.55 | 133.88 | -3.83 | +0.35 | 1,677 | 0.60 |
| 2027-03-19 | 177 | 12.50 | 59.64 | 0.05 | 1.40 | 472.00 | 60.28 | 124.31 | -0.64 | +0.32 | 34 | 1.35 |
| 2027-01-15 | 114 | 10.00 | 27.71 | 0.05 | 1.00 | 222.00 | 28.35 | 90.78 | -0.64 | +0.33 | 40 | 0.95 |
| 2027-03-19 | 177 | 10.00 | 27.71 | 0.70 | 2.50 | 287.00 | 36.65 | 75.59 | -8.94 | +0.52 | 1,100 | 1.80 |
As of September 23, 2026
Sell covered calls with the data behind you
Find the best ACHV covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→